ALPS ADVISORS INC

Position in MLYS — Mineralys Therapeutics, Inc.

CIK 1376113 Denver, CO

Position in MLYS

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$2,400,572

+$655,462 QoQ

Shares Held

88,976

+38.1% QoQ

Ownership

0.101%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#87

of 224 holders

Holding Since

Jun 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ALPS ADVISORS INC holds $213,436,831 across 115 Biotechnology names. MLYS ranks #28 (1.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RPRX	Royalty Pharma plc	315,335	$17,680,833
2	APGE	Apogee Therapeutics, Inc.	62,523	$8,298,677
3	CGON	CG Oncology, Inc.	89,218	$6,338,938
4	XENE	Xenon Pharmaceuticals Inc.	97,610	$5,891,739
5	ORKA	Oruka Therapeutics, Inc.	61,014	$5,806,702
6	DNTH	Dianthus Therapeutics, Inc. /DE/	55,281	$5,388,791
7	TVTX	Travere Therapeutics, Inc.	93,981	$5,339,060
8	DFTX	Definium Therapeutics, Inc.	110,388	$5,192,651

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,400,572	88,976	+38.1%	Shares	Defined	2026-07-29
2026-03-31	$1,745,110	64,419	-0.9%	Shares	Defined	2026-05-08
2025-12-31	$2,358,378	64,987	+87.5%	Shares	Defined	2026-02-12
2025-03-31	$550,464	34,664	-13.9%	Shares	Defined	2025-04-30
2024-12-31	$495,452	40,248	+5.2%	Shares	Defined	2025-02-13
2024-09-30	$463,377	38,264	-1.2%	Shares	Defined	2024-11-12
2024-06-30	$453,199	38,735	+33.6%	Shares	Defined	2024-08-13
2024-03-31	$374,247	28,989	+8.7%	Shares	Defined	2024-05-14
2023-12-31	$229,405	26,675	-11.5%	Shares	Defined	2024-02-14
2023-09-30	$286,707	30,148	+0.4%	Shares	Defined	2023-11-14
2023-06-30	$512,028	30,031	—	Shares	Defined	2023-08-14
No filing history on record for this holder in this stock.